Denali Therapeutics

South San Francisco

437 Total Employees

Year Founded: 2015

View Website

What's It Like to Work at Denali Therapeutics?

Updated on September 09, 2026

This page summarizes recurring themes identified from responses generated by popular LLMs to common candidate questions about Denali Therapeutics and has not been reviewed or approved by Denali Therapeutics.

What's it like to work at Denali Therapeutics?

Strengths in mission-driven science, platform innovation, and broad learning opportunities are accompanied by an intense pace and frequent shifts inherent to late-clinical biotechs. Together, these dynamics suggest a high-impact environment best suited to those comfortable with volatility and workload peaks, while those prioritizing stability may find the setting challenging.

Key Insight for Candidates

Denali’s mission-fueled push toward a first commercial launch via its BBB TransportVehicle platform creates outsized impact and learning, but magnifies volatility and deadline-driven intensity. Expect rapid priority shifts tied to regulatory outcomes—meaningful upside if they hit, abrupt pivots if they don’t.

Evidence in Action

Milestone Focused Launch Messaging — PDUFA April 5, 2026 for tividenofusp alfa and a $275M Royalty Pharma agreement underpin launch-readiness communications. Employees experience deadline-driven sprints, cross-functional coordination, and visible impact tied to regulatory milestones, shaping a high-urgency, approval-stage reputation.
On Site Lab Presence — 161 Oyster Point Blvd and required safety/ergonomic training signal strong on-site expectations for lab teams. Employees gain real-time collaboration and rapid lab access, while hybrid flexibility and privacy are more limited than fully remote setups, shaping perceptions of hands-on, science-first culture.

Positive Themes About Denali Therapeutics

Mission & Purpose: Work centers on serious neurodegenerative and rare diseases, anchored by a clear patient-centric mission. The platform focus on crossing the blood–brain barrier gives day-to-day work a strong sense of purpose.
Innovation & Products: The blood–brain-barrier TransportVehicle platform and a potential first approval for tividenofusp alfa signal distinctive, high-science innovation. Near-term regulatory catalysts and launch readiness create tangible product momentum.
Learning & Development: The transition toward first commercialization and frequent cross-functional collaboration offer broad learning and career-building opportunities. Individuals can gain end-to-end exposure from discovery through clinical and launch activities.

Considerations About Denali Therapeutics

Workload & Burnout: Fast timelines and milestone crunches drive workload spikes around pre-IND, IND, key readouts, and launch preparation. Long hours and strict documentation standards are common during these periods.
Change Fatigue: Portfolio pivots, evolving priorities with new data, and a 2024 reorganization indicate frequent shifts in direction. Such changes can create friction as the company scales processes and governance.
Job Insecurity: Layoffs tied to strategic refocus and program setbacks (including an FDA clinical hold) introduce uncertainty about role continuity. Even limited delays or misses can heighten pressure on teams.

NEW

What does AI tell candidates about your employer brand?

Get your free AI reputation report today.

See AI Report

These insights are generated using AI and may not reflect internal data or verified company information. They are intended solely for general informational purposes and should not be considered a definitive assessment of the company’s reputation. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.